Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 23 |
GO:0043226 | organelle | 2 | 23 |
GO:0043227 | membrane-bounded organelle | 3 | 23 |
GO:0043229 | intracellular organelle | 3 | 23 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
Related structures:
AlphaFold database: A4HT24
Term | Name | Level | Count |
---|---|---|---|
GO:0006325 | chromatin organization | 4 | 23 |
GO:0006479 | protein methylation | 4 | 23 |
GO:0006807 | nitrogen compound metabolic process | 2 | 23 |
GO:0008152 | metabolic process | 1 | 23 |
GO:0008213 | protein alkylation | 5 | 23 |
GO:0009987 | cellular process | 1 | 23 |
GO:0016043 | cellular component organization | 3 | 23 |
GO:0016570 | histone modification | 5 | 23 |
GO:0016571 | histone methylation | 5 | 23 |
GO:0018022 | peptidyl-lysine methylation | 5 | 23 |
GO:0018193 | peptidyl-amino acid modification | 5 | 23 |
GO:0018205 | peptidyl-lysine modification | 6 | 23 |
GO:0019538 | protein metabolic process | 3 | 23 |
GO:0032259 | methylation | 2 | 23 |
GO:0034729 | histone H3-K79 methylation | 7 | 23 |
GO:0034968 | histone lysine methylation | 6 | 23 |
GO:0036211 | protein modification process | 4 | 23 |
GO:0043170 | macromolecule metabolic process | 3 | 23 |
GO:0043412 | macromolecule modification | 4 | 23 |
GO:0043414 | macromolecule methylation | 3 | 23 |
GO:0044237 | cellular metabolic process | 2 | 23 |
GO:0044238 | primary metabolic process | 2 | 23 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 23 |
GO:0050789 | regulation of biological process | 2 | 23 |
GO:0050794 | regulation of cellular process | 3 | 23 |
GO:0051726 | regulation of cell cycle | 4 | 23 |
GO:0065007 | biological regulation | 1 | 23 |
GO:0071704 | organic substance metabolic process | 2 | 23 |
GO:0071840 | cellular component organization or biogenesis | 2 | 23 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 23 |
GO:0000075 | cell cycle checkpoint signaling | 4 | 2 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006259 | DNA metabolic process | 4 | 2 |
GO:0006281 | DNA repair | 5 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006950 | response to stress | 2 | 2 |
GO:0006974 | DNA damage response | 4 | 2 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0009605 | response to external stimulus | 2 | 1 |
GO:0009607 | response to biotic stimulus | 2 | 1 |
GO:0010564 | regulation of cell cycle process | 5 | 2 |
GO:0010948 | negative regulation of cell cycle process | 6 | 2 |
GO:0020033 | antigenic variation | 7 | 1 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 2 |
GO:0033554 | cellular response to stress | 3 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 2 |
GO:0042783 | evasion of host immune response | 6 | 1 |
GO:0043207 | response to external biotic stimulus | 3 | 1 |
GO:0044403 | biological process involved in symbiotic interaction | 2 | 1 |
GO:0044419 | biological process involved in interspecies interaction between organisms | 1 | 1 |
GO:0045786 | negative regulation of cell cycle | 5 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051098 | regulation of binding | 3 | 2 |
GO:0051101 | regulation of DNA binding | 4 | 2 |
GO:0051701 | biological process involved in interaction with host | 3 | 1 |
GO:0051707 | response to other organism | 2 | 1 |
GO:0051716 | cellular response to stimulus | 2 | 2 |
GO:0052173 | response to defenses of other organism | 3 | 1 |
GO:0052200 | response to host defenses | 4 | 1 |
GO:0052572 | response to host immune response | 5 | 1 |
GO:0065009 | regulation of molecular function | 2 | 2 |
GO:0075136 | response to host | 3 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 2 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 2 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 23 |
GO:0008168 | methyltransferase activity | 4 | 23 |
GO:0008170 | N-methyltransferase activity | 5 | 23 |
GO:0008276 | protein methyltransferase activity | 3 | 23 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 23 |
GO:0016278 | lysine N-methyltransferase activity | 6 | 23 |
GO:0016279 | protein-lysine N-methyltransferase activity | 4 | 23 |
GO:0016740 | transferase activity | 2 | 23 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 23 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 5 | 23 |
GO:0031151 | histone H3K79 methyltransferase activity | 6 | 23 |
GO:0042054 | histone methyltransferase activity | 4 | 23 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 23 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.362 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.569 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.531 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.393 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.492 |
CLV_PCSK_PC1ET2_1 | 100 | 102 | PF00082 | 0.397 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.584 |
CLV_PCSK_PC7_1 | 61 | 67 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 114 | 118 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.357 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.685 |
DEG_SCF_FBW7_1 | 116 | 122 | PF00400 | 0.264 |
DEG_SCF_FBW7_1 | 64 | 71 | PF00400 | 0.511 |
DOC_CKS1_1 | 116 | 121 | PF01111 | 0.264 |
DOC_CKS1_1 | 204 | 209 | PF01111 | 0.337 |
DOC_CKS1_1 | 45 | 50 | PF01111 | 0.571 |
DOC_CYCLIN_RxL_1 | 109 | 118 | PF00134 | 0.388 |
DOC_MAPK_gen_1 | 184 | 195 | PF00069 | 0.305 |
DOC_MAPK_gen_1 | 96 | 105 | PF00069 | 0.472 |
DOC_MAPK_MEF2A_6 | 188 | 195 | PF00069 | 0.291 |
DOC_PP1_RVXF_1 | 244 | 251 | PF00149 | 0.286 |
DOC_PP4_FxxP_1 | 226 | 229 | PF00568 | 0.426 |
DOC_SPAK_OSR1_1 | 21 | 25 | PF12202 | 0.656 |
DOC_SPAK_OSR1_1 | 292 | 296 | PF12202 | 0.236 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.392 |
DOC_USP7_MATH_1 | 95 | 99 | PF00917 | 0.567 |
DOC_USP7_MATH_2 | 48 | 54 | PF00917 | 0.550 |
DOC_USP7_UBL2_3 | 96 | 100 | PF12436 | 0.445 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.426 |
DOC_WW_Pin1_4 | 203 | 208 | PF00397 | 0.395 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.516 |
DOC_WW_Pin1_4 | 64 | 69 | PF00397 | 0.315 |
LIG_14-3-3_CanoR_1 | 21 | 29 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 237 | 242 | PF00244 | 0.402 |
LIG_APCC_ABBA_1 | 260 | 265 | PF00400 | 0.187 |
LIG_BRCT_BRCA1_1 | 144 | 148 | PF00533 | 0.286 |
LIG_deltaCOP1_diTrp_1 | 276 | 286 | PF00928 | 0.286 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.403 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.316 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.415 |
LIG_FHA_1 | 229 | 235 | PF00498 | 0.302 |
LIG_FHA_1 | 243 | 249 | PF00498 | 0.321 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.291 |
LIG_FHA_2 | 206 | 212 | PF00498 | 0.380 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.475 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.280 |
LIG_LIR_Apic_2 | 183 | 189 | PF02991 | 0.264 |
LIG_LIR_Gen_1 | 173 | 182 | PF02991 | 0.299 |
LIG_LIR_Gen_1 | 276 | 284 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 285 | 294 | PF02991 | 0.261 |
LIG_LIR_Gen_1 | 85 | 94 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 134 | 139 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 173 | 178 | PF02991 | 0.299 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.384 |
LIG_NRBOX | 199 | 205 | PF00104 | 0.236 |
LIG_Pex14_2 | 148 | 152 | PF04695 | 0.323 |
LIG_PTB_Apo_2 | 220 | 227 | PF02174 | 0.318 |
LIG_SH2_CRK | 186 | 190 | PF00017 | 0.264 |
LIG_SH2_CRK | 94 | 98 | PF00017 | 0.395 |
LIG_SH2_NCK_1 | 94 | 98 | PF00017 | 0.423 |
LIG_SH2_STAT3 | 277 | 280 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 277 | 280 | PF00017 | 0.332 |
LIG_SH3_2 | 56 | 61 | PF14604 | 0.372 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.532 |
LIG_SH3_3 | 53 | 59 | PF00018 | 0.392 |
LIG_SUMO_SIM_par_1 | 101 | 106 | PF11976 | 0.363 |
LIG_TRAF2_1 | 77 | 80 | PF00917 | 0.314 |
LIG_UBA3_1 | 127 | 133 | PF00899 | 0.371 |
LIG_UBA3_1 | 220 | 228 | PF00899 | 0.302 |
MOD_CDK_SPK_2 | 44 | 49 | PF00069 | 0.601 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.391 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.633 |
MOD_CK1_1 | 205 | 211 | PF00069 | 0.394 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.615 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.561 |
MOD_CK2_1 | 74 | 80 | PF00069 | 0.500 |
MOD_GlcNHglycan | 104 | 108 | PF01048 | 0.537 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.358 |
MOD_GlcNHglycan | 35 | 39 | PF01048 | 0.640 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.371 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.372 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.276 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.205 |
MOD_GSK3_1 | 228 | 235 | PF00069 | 0.274 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.475 |
MOD_N-GLC_1 | 128 | 133 | PF02516 | 0.294 |
MOD_N-GLC_1 | 142 | 147 | PF02516 | 0.284 |
MOD_N-GLC_1 | 68 | 73 | PF02516 | 0.368 |
MOD_NEK2_1 | 294 | 299 | PF00069 | 0.385 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.256 |
MOD_Plk_2-3 | 132 | 138 | PF00069 | 0.299 |
MOD_Plk_2-3 | 285 | 291 | PF00069 | 0.321 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.336 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.145 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.280 |
MOD_Plk_4 | 205 | 211 | PF00069 | 0.315 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.426 |
MOD_ProDKin_1 | 203 | 209 | PF00069 | 0.395 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.503 |
MOD_ProDKin_1 | 64 | 70 | PF00069 | 0.318 |
TRG_DiLeu_BaEn_1 | 173 | 178 | PF01217 | 0.410 |
TRG_DiLeu_BaEn_2 | 289 | 295 | PF01217 | 0.426 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.404 |
TRG_ER_diArg_1 | 4 | 7 | PF00400 | 0.604 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.523 |
TRG_NES_CRM1_1 | 273 | 285 | PF08389 | 0.347 |
TRG_NLS_MonoExtC_3 | 6 | 12 | PF00514 | 0.632 |
TRG_NLS_MonoExtC_3 | 98 | 104 | PF00514 | 0.478 |
TRG_NLS_MonoExtN_4 | 5 | 11 | PF00514 | 0.602 |
TRG_NLS_MonoExtN_4 | 96 | 103 | PF00514 | 0.438 |
TRG_Pf-PMV_PEXEL_1 | 21 | 26 | PF00026 | 0.609 |
TRG_Pf-PMV_PEXEL_1 | 246 | 251 | PF00026 | 0.257 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P397 | Leptomonas seymouri | 73% | 100% |
A0A0N0P563 | Leptomonas seymouri | 52% | 100% |
A0A0S4IIL9 | Bodo saltans | 56% | 96% |
A0A0S4IQV1 | Bodo saltans | 60% | 100% |
A0A1X0NK69 | Trypanosomatidae | 64% | 100% |
A0A1X0NY45 | Trypanosomatidae | 53% | 100% |
A0A3R7LQU8 | Trypanosoma rangeli | 52% | 100% |
A0A3S5H5V6 | Leishmania donovani | 99% | 100% |
A0A3S7WVS5 | Leishmania donovani | 55% | 100% |
A0A422NTB2 | Trypanosoma rangeli | 64% | 100% |
A4H4U6 | Leishmania braziliensis | 84% | 100% |
A4HBH1 | Leishmania braziliensis | 54% | 100% |
A4HYJ5 | Leishmania infantum | 55% | 100% |
C9ZHT8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
C9ZUW8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9AL12 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
E9AUE2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 55% | 100% |
Q4QD41 | Leishmania major | 55% | 100% |
Q4QIU2 | Leishmania major | 96% | 100% |
V5ATA1 | Trypanosoma cruzi | 63% | 100% |
V5BVL1 | Trypanosoma cruzi | 48% | 100% |